INOVIO PHARMACEUTICALS, INC. Gain (Loss) on Investments
INOVIO PHARMACEUTICALS, INC. (INO) reported Gain (Loss) on Investments of $153.25 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2021-08-09
- INOVIO PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2021-06-30 was $163.40K.
- INOVIO PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2021-03-31 was -$10.15K.
- INOVIO PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2020-12-31 was -$16.49K, a 106.92% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2020-09-30 was $4.22K, a 97.08% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2020 was -$588.27K, a 223.49% decline from fiscal 2019.
- INOVIO PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2019 was $476.37K.
- INOVIO PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2018 was -$1.34M.
- INOVIO PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2017 was -$215.42K.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 9 month as first filed | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|---|
| 2021-06-30 | $163.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $153.25K 10-Q · filed 2021-08-09 | $136.76K derived: sum of 3 quarters · filed 2021-08-09 | $140.98K derived: sum of 4 quarters · filed 2021-08-09 | |
| 2021-03-31 | -$10.15K 10-Q · filed 2021-05-10 | -$26.64K derived: sum of 2 quarters · filed 2021-05-10 | -$22.42K derived: sum of 3 quarters · filed 2021-05-10 | -$122.93K derived: sum of 4 quarters · filed 2021-08-09 | |
| 2020-12-31 | -$16.49K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$12.27K derived: sum of 2 quarters · filed 2021-03-01 | -$112.78K derived: sum of 3 quarters · filed 2021-08-09 | -$588.27K 10-K · filed 2021-03-01 | |
| 2020-09-30 | $4.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$96.29K derived: sum of 2 quarters · filed 2021-08-09 | -$571.78K 10-Q · filed 2020-11-09 | -$333.49K derived: sum of 4 quarters · filed 2021-08-09 | |
| 2020-06-30 | -$100.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$576.00K 10-Q · filed 2021-08-09 | -$337.72K derived: sum of 3 quarters · filed 2021-08-09 | -$192.91K derived: sum of 4 quarters · filed 2021-08-09 | |
| 2020-03-31 | -$475.49K 10-Q · filed 2021-05-10 | -$237.21K derived: sum of 2 quarters · filed 2021-05-10 | -$92.39K derived: sum of 3 quarters · filed 2021-05-10 | $36.72K derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $238.28K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $383.10K derived: sum of 2 quarters · filed 2021-03-01 | $512.21K derived: sum of 3 quarters · filed 2021-03-01 | $476.37K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $144.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $273.92K derived: sum of 2 quarters · filed 2020-11-09 | $238.08K 10-Q · filed 2020-11-09 | -$546.05K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $129.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $93.27K 10-Q · filed 2020-08-10 | -$690.86K derived: sum of 3 quarters · filed 2021-03-01 | -$874.91K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$35.84K 10-Q · filed 2020-05-11 | -$819.97K derived: sum of 2 quarters · filed 2021-03-01 | -$1.00M derived: sum of 3 quarters · filed 2021-03-01 | -$1.12M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | -$784.13K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$968.18K derived: sum of 2 quarters · filed 2021-03-01 | -$1.09M derived: sum of 3 quarters · filed 2021-03-01 | -$1.34M 10-K · filed 2021-03-01 | |
| 2018-09-30 | -$184.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$304.56K derived: sum of 2 quarters · filed 2019-11-12 | -$557.88K 10-Q · filed 2019-11-12 | -$695.41K derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-06-30 | -$120.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$373.82K 10-Q · filed 2019-08-08 | -$511.36K derived: sum of 3 quarters · filed 2020-03-12 | -$521.88K derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-03-31 | -$253.32K 10-Q · filed 2019-05-09 | -$390.85K derived: sum of 2 quarters · filed 2020-03-12 | -$401.37K derived: sum of 3 quarters · filed 2020-03-12 | -$417.03K derived: sum of 4 quarters · filed 2020-03-12 | |
| 2017-12-31 | -$137.53K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$148.06K derived: sum of 2 quarters · filed 2020-03-12 | -$163.72K derived: sum of 3 quarters · filed 2020-03-12 | -$215.42K 10-K · filed 2020-03-12 | |
| 2017-09-30 | -$10.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$26.18K derived: sum of 2 quarters · filed 2018-11-08 | -$77.89K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$15.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$67.37K 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | -$51.71K 10-Q · filed 2018-05-09 | ||||
| 2016-09-30 | $44.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $49.46K derived: sum of 2 quarters · filed 2017-11-08 | $44.93K 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $4.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | |||
| 2016-03-31 | -$4.53K 10-Q · filed 2017-05-10 | ||||
| 2015-09-30 | $1.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.18K derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | -$1.18K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$1.18K 10-Q · filed 2015-08-10 | |||
| 2015-03-31 | -$1.18K 10-Q · filed 2016-05-09 | ||||
| 2014-09-30 | -$1.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$1.50K derived: sum of 2 quarters · filed 2015-11-09 | -$1.50K 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |